Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks

View ORCID ProfileLuke B Snell, Chloe L Fisher, Usman Taj, View ORCID ProfileBlair Merrick, View ORCID ProfileAdela Alcolea-Medina, View ORCID ProfileThemoula Charalampous, View ORCID ProfileAdrian W Signell, View ORCID ProfileHarry D Wilson, View ORCID ProfileGilberto Betancor, View ORCID ProfileMark Tan Kia Ik, Emma Cunningham, View ORCID ProfilePenelope R Cliff, View ORCID ProfileSuzanne Pickering, View ORCID ProfileRui Pedro Galao, Rahul Batra, View ORCID ProfileStuart J D Neil, View ORCID ProfileMichael H Malim, View ORCID ProfileKatie J Doores, View ORCID ProfileSam T Douthwaite, View ORCID ProfileGaia Nebbia, View ORCID ProfileJonathan D Edgeworth, View ORCID ProfileAli R Awan, The COVID-19 Genomics UK (COG-UK) consortium
doi: https://doi.org/10.1101/2020.11.17.20232827
Luke B Snell
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luke B Snell
Chloe L Fisher
3Genomics Innovation Unit, Guy’s and St. Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Usman Taj
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Blair Merrick
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Blair Merrick
Adela Alcolea-Medina
5Infection Sciences, Viapath, St Thomas’ Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adela Alcolea-Medina
Themoula Charalampous
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Themoula Charalampous
Adrian W Signell
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adrian W Signell
Harry D Wilson
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harry D Wilson
Gilberto Betancor
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gilberto Betancor
Mark Tan Kia Ik
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Tan Kia Ik
Emma Cunningham
5Infection Sciences, Viapath, St Thomas’ Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Penelope R Cliff
5Infection Sciences, Viapath, St Thomas’ Hospital, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Penelope R Cliff
Suzanne Pickering
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Suzanne Pickering
Rui Pedro Galao
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rui Pedro Galao
Rahul Batra
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart J D Neil
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart J D Neil
Michael H Malim
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael H Malim
Katie J Doores
4Department of Infectious Diseases, King’s College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katie J Doores
Sam T Douthwaite
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sam T Douthwaite
Gaia Nebbia
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gaia Nebbia
Jonathan D Edgeworth
1Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, School of Immunology and Microbial Sciences, King’s College London
2Directorate of Infection, Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan D Edgeworth
Ali R Awan
3Genomics Innovation Unit, Guy’s and St. Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ali R Awan
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Many healthcare facilities report SARS-CoV-2 outbreaks but transmission analysis is complicated by the high prevalence of infection and limited viral genetic diversity. The contribution of different vectors to nosocomial infection or the effectiveness of interventions is therefore currently unclear. Detailed epidemiological and viral nanopore sequence data were analysed from 574 consecutive patients with a PCR positive SARS-CoV-2 test between March 13th and March 31st, when the pandemic first impacted on a large, multisite healthcare institution in London. During this time the first major preventative interventions were introduced, including progressive community social distancing (CSD) policies leading to mandatory national lockdown, exclusion of hospital visitors, and introduction of universal surgical facemask-use by healthcare-workers (HCW). Incidence of nosocomial cases, community SARS-CoV-2 cases and infection in a cohort of 228 HCWs followed the same dynamic course, decreasing shortly after introduction of CSD measures and prior to the main hospital-based interventions. We investigated clusters involving nosocomial cases based on overlapping ward-stays during the 14-day incubation period and SARS-CoV-2 genome sequence similarity. Our method placed 63 (79%) of 80 sequenced probable and definite nosocomial cases into 14 clusters containing a median of 4 patients (min 2, max 19) No genetic support was found for the majority of epidemiological clusters (31/44, 70%) and genomics revealed multiple contemporaneous outbreaks within single epidemiological clusters. We included a measure of hospital enrichment compared to community cases to increase confidence in our clusters, which were 1-14 fold enriched. Applying genomics, we could provide a robust estimate of the incubation period for nosocomial transmission, with a median lower bound and upper bound of 6 and 9 days respectively. Six (43%) clusters spanned multiple wards, with evidence of cryptic transmission, and community-onset cases could not be identified in more than half the clusters, particularly on the elective hospital site, implicating HCW as vectors of transmission. Taken together these findings suggest that CSD had the dominant impact on reducing nosocomial transmission by reducing HCW infection.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the King's Together Multi and Interdisciplinary Research Scheme (Wellcome Trust Revenue Retention Award, and the National Institute for Health Research (NIHR) Biomedical Research Centre programme of Infection and Immunity (RJ112/N027) based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Favourable opinion to conduct this work was granted by the North West Preston Research Ethics Committee (Reference 18/NW/0584) The COVID-19 Genomics UK (COG-UK) consortium study protocol was approved by the Public Health England Research Ethics and Governance Group (reference: R&D NR0195).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Full list of consortium names and affiliations are in the appendix.

  • ↵6 https://www.cogconsortium.uk

  • FUNDINGThis work was supported by the King’s Together Multi and Interdisciplinary Research Scheme (Wellcome Trust Revenue Retention Award, and the National Institute for Health Research (NIHR) Biomedical Research Centre programme of Infection and Immunity (RJ112/N027) based at Guy’s and St Thomas’ National Health Service NHS) Foundation Trust and King’s College London.

  • COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute.

  • ETHICS Favourable opinion to conduct this work was granted by the North West Preston Research Ethics Committee (Reference 18/NW/0584)

  • The COVID-19 Genomics UK (COG-UK) consortium study protocol was approved by the Public Health England Research Ethics and Governance Group (reference: R&D NR0195).

Data Availability

Sequence data will be available at ENA Study accession number is: PRJEB41373 Study name is: ena-STUDY-KING'S COLLEGE LONDON-17-11-2020-01:31:23:025-468

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks
Luke B Snell, Chloe L Fisher, Usman Taj, Blair Merrick, Adela Alcolea-Medina, Themoula Charalampous, Adrian W Signell, Harry D Wilson, Gilberto Betancor, Mark Tan Kia Ik, Emma Cunningham, Penelope R Cliff, Suzanne Pickering, Rui Pedro Galao, Rahul Batra, Stuart J D Neil, Michael H Malim, Katie J Doores, Sam T Douthwaite, Gaia Nebbia, Jonathan D Edgeworth, Ali R Awan, The COVID-19 Genomics UK (COG-UK) consortium
medRxiv 2020.11.17.20232827; doi: https://doi.org/10.1101/2020.11.17.20232827
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks
Luke B Snell, Chloe L Fisher, Usman Taj, Blair Merrick, Adela Alcolea-Medina, Themoula Charalampous, Adrian W Signell, Harry D Wilson, Gilberto Betancor, Mark Tan Kia Ik, Emma Cunningham, Penelope R Cliff, Suzanne Pickering, Rui Pedro Galao, Rahul Batra, Stuart J D Neil, Michael H Malim, Katie J Doores, Sam T Douthwaite, Gaia Nebbia, Jonathan D Edgeworth, Ali R Awan, The COVID-19 Genomics UK (COG-UK) consortium
medRxiv 2020.11.17.20232827; doi: https://doi.org/10.1101/2020.11.17.20232827

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5130)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)